CRH Medical (TSE:CRH) released its quarterly earnings data on Wednesday. The company reported C$0.03 earnings per share for the quarter, meeting the consensus estimate of C$0.03, reports. The firm had revenue of C$42.33 million during the quarter, compared to analysts’ expectations of C$41.45 million.

CRH Medical stock traded down C$0.10 during mid-day trading on Friday, hitting C$3.86. 69,982 shares of the company were exchanged, compared to its average volume of 130,524. The company has a debt-to-equity ratio of 52.51, a quick ratio of 1.89 and a current ratio of 1.99. The company has a market capitalization of $286.40 million and a price-to-earnings ratio of 45.41. CRH Medical has a 12-month low of C$3.09 and a 12-month high of C$5.91.

Separately, TD Securities dropped their price target on CRH Medical from C$6.50 to C$5.50 and set a “buy” rating for the company in a research report on Wednesday, January 9th.

ILLEGAL ACTIVITY WARNING: “CRH Medical (CRH) Announces Quarterly Earnings Results, Hits Estimates” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Recommended Story: Is the Dow Jones Industrial Average (DJIA) still relevant?

Earnings History for CRH Medical (TSE:CRH)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.